4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-18-008437
Chief Financial Officer sold 10,099 shares at $287.46 ($2,903,059)
- Chief Financial Officer acquired 7,957 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneebaum Marc R Chief Financial Officer | 2018-06-11 | Option exercise | +5,223 | $99.75 | $520,994 | 49,033 | D |
| Schneebaum Marc R Chief Financial Officer | 2018-06-11 | Option exercise | +2,734 | $61.60 | $168,414 | 51,767 | D |
| Schneebaum Marc R Chief Financial Officer | 2018-06-11 | Sale | −10,099 | $287.46 | $2,903,059 | 41,668 | D |
| Derivatives | |||||||
| Schneebaum Marc R Chief Financial Officer | 2018-06-11 | Option exercise · Stock Option | −5,223 | 1,205 | D | ||
| Schneebaum Marc R Chief Financial Officer | 2018-06-11 | Option exercise · Stock Option | −2,734 | 1,640 | D | ||
| Open-market sales · 10,099 sh · avg $287.46 · $2,903,059 | |||||||
Loading xslF345X03/edgar.xml…